13F filer · CIK 1510481 ↗
Sarasin & Partners LLP
You are looking at Q1 2025. See the latest, Q3 2026 →
Reported value
$9.22B
+1.7% on the quarter before
Positions
81
22 new · 3 sold out
Top 10
46.9%
of the value
Est. gain
−$301.1M
on stocks held all quarter
Est. return
−3.9%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Sarasin & Partners LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$290.3MNew · 0.0% → 3.1%+554,313 shares
- Zoetis Inc~$255.8MNew · 0.0% → 2.8%+1,553,855 shares
- TSMC~$243.9MNew · 0.0% → 2.6%+1,469,127 shares
- Thermo Fisher Scientific Inc~$187.1MNew · 0.0% → 2.0%+376,074 shares
- Tetra Tech Inc New~$135.4MNew · 0.0% → 1.5%+4,628,564 shares
- Chipotle Mexican Grill Inc~$113.5MAdded · 0.1% → 1.4%+2,260,016 shares
- Smith A O Corp~$74.2MNew · 0.0% → 0.8%+1,134,952 shares
- ServiceNow~$59.6MNew · 0.0% → 0.6%+74,832 shares
- Microsoft~$54.1MAdded · 9.2% → 8.6%+144,101 shares
- Fortinet~$52.3MAdded · 2.0% → 2.6%+542,898 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$217.6MCut · 7.6% → 4.3%−979,589 shares
- Cme Group Inc~$149.4MCut · 4.4% → 3.4%−563,121 shares
- Home Depot Inc~$97.1MCut · 4.0% → 2.6%−265,072 shares
- Meta~$88.3MCut · 5.1% → 4.0%−153,198 shares
- Jpmorgan Chase & Co.~$76.2MCut · 3.7% → 2.9%−310,476 shares
- Nvidia~$74.5MCut · 6.7% → 4.5%−687,268 shares
- Ecolab Inc~$69.8MCut · 0.8% → 0.1%−275,252 shares
- Amazon~$65.7MCut · 6.9% → 5.2%−345,569 shares
- Mastercard~$61.3MCut · 5.1% → 4.5%−111,883 shares
- Cisco~$57.2MCut · 1.8% → 1.2%−926,678 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +7.3% · price −10.9% | 8.6% | $796.4M | −$91.2M | ||||||||
| AmazonCOM · shares −12% · price −13.3% | 5.2% | $477.9M | −$73.2M | ||||||||
| NvidiaCOM · shares −15% · price −19.3% | 4.5% | $417.5M | −$99.8M | ||||||||
| MastercardCL A · shares −13% · price +4.1% | 4.5% | $416.5M | +$16.4M | ||||||||
| AlphabetCAP STK CL A · shares −4.8% · price −18.3% | 4.3% | $396.3M | −$88.8M | ||||||||
| AppleCOM · shares −35% · price −11.3% | 4.3% | $396.2M | −$50.5M | ||||||||
| Otis Worldwide CorpCOM · shares −10% · price +11.4% | 4.1% | $375.9M | +$38.6M | ||||||||
| MetaCL A · shares −19% · price −1.6% | 4.0% | $370.6M | −$5.9M | ||||||||
| Colgate Palmolive CoCOM · shares +9.5% · price +3.1% | 3.9% | $363.0M | +$9.9M | ||||||||
| Cme Group IncCOM · shares −32% · price +14.2% | 3.4% | $311.1M | +$38.8M | ||||||||
| Unitedhealth Group IncCOM · shares New | 3.1% | $290.3M | — | ||||||||
| Jpmorgan Chase & Co.COM · shares −22% · price +2.3% | 2.9% | $263.6M | +$6.0M | ||||||||
| Zoetis IncCL A · shares New | 2.8% | $255.8M | — | ||||||||
| Emerson ElectricCOM · shares +26% · price −11.5% | 2.6% | $244.1M | −$25.2M | ||||||||
| TSMCSPONSORED ADS · shares New | 2.6% | $243.9M | — | ||||||||
| Home Depot IncCOM · shares −29% · price −5.8% | 2.6% | $243.4M | −$14.9M | ||||||||
| FortinetCOM · shares +28% · price +1.9% | 2.6% | $240.1M | +$3.5M | ||||||||
| Blackrock IncCOM · shares −5.4% · price −7.7% | 2.5% | $231.1M | −$19.2M | ||||||||
| Costco Whsl Corp NewCOM · shares −0.6% · price +3.2% | 2.4% | $225.1M | +$7.0M | ||||||||
| Deere & CoCOM · shares −11% · price +10.8% | 2.3% | $213.8M | +$20.8M | ||||||||
| Moody's CorporationCOM · shares −21% · price −1.6% | 2.3% | $207.7M | −$3.4M | ||||||||
| Eli LillyCOM · shares −11% · price +7.0% | 2.0% | $188.4M | +$12.3M | ||||||||
| Thermo Fisher Scientific IncCOM · shares New | 2.0% | $187.1M | — | ||||||||
| American TowerCOM · shares −14% · price +18.6% | 1.9% | $175.1M | +$27.5M | ||||||||
| Amgen IncCOM · shares +4.7% · price +19.5% | 1.9% | $173.7M | +$27.1M | ||||||||
| Total · 81 positions | 100% | $9.22B | −$301.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 59 stocks held throughout, down $301.1M (−3.9%).
- Cme Group Inc+$38.8M+14%
- Otis Worldwide Corp+$38.6M+11%
- American Tower+$27.5M+19%
- Amgen Inc+$27.1M+20%
- Deere & Co+$20.8M+11%
- Apple−$50.5M−11%
- Amazon−$73.2M−13%
- Alphabet−$88.8M−18%
- Microsoft−$91.2M−11%
- Nvidia−$99.8M−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 13, 2026 | $8.93B+5% | SEC ↗ |
| Q2 2026 | Jul 7, 2026 | $8.54B+4% | SEC ↗ |
| Q1 2026 | Apr 13, 2026 | $8.20B−15% | SEC ↗ |
| Q4 2025 | Jan 8, 2026 | $9.63B−5% | SEC ↗ |
| Q3 2025 | Oct 10, 2025 | $10.19B+1% | SEC ↗ |
| Q2 2025 | Jul 9, 2025 | $10.05B+9% | SEC ↗ |
| Q1 2025 | Apr 15, 2025 (amended) | $9.22B+2% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $9.06B−14% | SEC ↗ |
| Q3 2024 | Oct 9, 2024 | $10.60B−6% | SEC ↗ |
| Q2 2024 | Jul 19, 2024 | $11.29B+11% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $10.16B+12% | SEC ↗ |
| Q4 2023 | Jan 10, 2024 | $9.10B+14% | SEC ↗ |
| Q3 2023 | Oct 5, 2023 | $8.01B−7% | SEC ↗ |
| Q2 2023 | Jul 11, 2023 | $8.62B−54% | SEC ↗ |
| Q1 2023 | Apr 27, 2023 (amended) | $18.57B+143% | SEC ↗ |
| Q4 2022 | Jan 30, 2023 | $7.64B+6% | SEC ↗ |
| Q3 2022 | Oct 18, 2022 | $7.22B−9% | SEC ↗ |
| Q2 2022 | Jul 13, 2022 | $7.93B−20% | SEC ↗ |
| Q1 2022 | Apr 11, 2022 | $9.95B−9% | SEC ↗ |
| Q4 2021 | Jan 19, 2022 | $10.98B+11% | SEC ↗ |
| Q3 2021 | Oct 22, 2021 | $9.91B+3% | SEC ↗ |
| Q2 2021 | Jul 13, 2021 | $9.58B+13% | SEC ↗ |
| Q1 2021 | Apr 29, 2021 | $8.48B+12% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $7.56B+9% | SEC ↗ |
| Q3 2020 | Nov 9, 2020 | $6.91B+11% | SEC ↗ |
| Q2 2020 | Jul 17, 2020 | $6.25B+23% | SEC ↗ |
| Q1 2020 | Apr 30, 2020 | $5.09B−22% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $6.54B+8% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $6.04B+6% | SEC ↗ |
| Q2 2019 | Jul 18, 2019 | $5.72B+10% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $5.19B+13% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $4.60B−13% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $5.31B+4% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $5.09B−0% | SEC ↗ |
| Q1 2018 | May 1, 2018 | $5.11B−1% | SEC ↗ |
| Q4 2017 | Feb 6, 2018 | $5.15B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $4.96B−3% | SEC ↗ |
| Q2 2017 | Aug 3, 2017 | $5.11B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $5.14B−13% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $5.91B−7% | SEC ↗ |
| Q3 2016 | Oct 14, 2016 | $6.38B+6% | SEC ↗ |
| Q2 2016 | Jul 14, 2016 | $6.02B−2% | SEC ↗ |
| Q1 2016 | Apr 27, 2016 | $6.13B | SEC ↗ |